Brand Switching in Healthcare Treatments

Understand and Optimize Treatment Dynamics with Verana Health’s Brand Switching Solution

In a competitive healthcare market, understanding why patients and prescribers switch between brands is crucial for refining strategies, improving product positioning, and increasing market share.

Verana Health’s Brand Switching solution in healthcare treatments leverages real-world evidence (RWE) derived from exclusive real-world data within the American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight) to help you uncover key factors driving brand loyalty and changes in treatment patterns, even when therapies share a code.

Our Ophthalmology Qdata® provides even deeper insights into the competitive landscape of ophthalmic therapies by including curated variables extracted from EHR clinical notes.

What Is Brand Switching in Healthcare Treatments?

Brand switching occurs when a patient transitions from one medication or therapy to another, often driven by efficacy, cost, side effects, or prescriber preference.

Verana Health’s Brand Switching solution provides detailed insights into these transitions across various ophthalmic treatments, including anti-VEGF therapies. By understanding these behaviors, life sciences companies can optimize their product offerings, enhance patient care, and adapt marketing strategies to real-world treatment dynamics.

Meet with the Verana Health Team or View a Demo

Schedule Now

Key Features of Brand Switching in Healthcare Treatments

Comprehensive Transition Analysis

Identify and analyze brand switching and patterns across multiple treatments. Our solution provides a deep understanding of the following:

  • Brand switching: Track the clinical or commercial factors that prompt a change in therapy.
  • Patient outcomes: Assess how switching affects patient outcomes and overall care.
  • Frequency of switching: Identify characteristics of which groups of patients switch therapies, how often they switch, and the time intervals between transitions.

Competitive Landscape Insights

Understand how your therapies are performing relative to competitor brands, even if they share a code. The Brand Switching healthcare treatment solution helps you determine:

  • Market share shifts: Track changes in market share as patients and prescribers move from one brand to another.
  • Competitor vulnerabilities: Identify opportunities where your product can capture market share by addressing unmet needs or gaps in competitor offerings.
  • Prescriber preferences: Discover which factors are influencing prescriber decisions to switch treatments and how you can leverage these insights to boost your therapy’s uptake.

Patient Journey Mapping

Visualize patient journeys as they move between therapies, from the initial treatment to subsequent changes. By mapping these transitions, you can:

  • Identify key touchpoints in the patient journey that drive switching behavior.
  • Optimize engagement strategies to prevent switching away from your brand.
  • Enhance patient retention by addressing the pain points that lead to a change in therapy.

Anti-VEGF Market Tracker

For life sciences companies in the ophthalmology space, our Qdata Anti-VEGF Market Tracker offers unparalleled insights into the usage of anti-VEGF therapies down to the brand level. This powerful tool provides:

  • Real-time tracking of adoption rates for anti-VEGF treatments, track rolling market scare, KPIs of interest, brand loyalty, and switching behaviors.
  • Key trends to understand prescriber preferences and practice patterns that are driving changes in the anti-VEGF market.
  • Real-world usage of your therapy, including brand switching or brand usage by indication.

The Qdata Anti-VEGF Market Tracker enables you to stay ahead of competitors by understanding how your therapy is performing in a highly competitive market.

Why Choose Verana Health’s Brand Switching Healthcare Treatment Solution?

  • Deep Market Understanding: Our solution gives you unparalleled insights into patient and prescriber behaviors, allowing you to adapt to shifting market dynamics.
  • Updated Data: With continuously updated data from the IRIS Registry, you can track brand switching trends to ensure your strategies are informed by trusted, recent data.
  • Actionable Insights: Insights that help you understand how brand switching is impacting your market position with curated EHR data that can be segmented by brand, practice details, and more.

Featured Content

Research

Impact of Anti-VEGF Treatment and Patient Characteristics on Vision Outcomes in nAMD: Up to 6-Year Analysis of the AAO IRIS® Registry

October 2023
→
Blog

A Powerful and Unique Tool for the Anti-VEGF Market

April 2023
→
Press

Verana Health Unveils Qdata Anti-VEGF Market Tracker

March 2023
→
VeranaHealth_Logo

Contact us to learn more about brand switching solutions.